Hilotherapy for Prevention of Chemotherapy-induced Peripheral Polyneuropathy - a Unicentric, Prospective-controlled, Randomized Clinical Trial for Comparison of Local Hilotherapy Vs. No Therapy to Prevent Peripheral Polyneuropathy During Taxan-based Chemotherapy Regimen
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Prospective study of hilotherapy of hands and feet as prevention of chemotherapy-induced peripheral polyneuropathy induced by Taxan-based chemotherapy regimen that are used in the therapy of breast cancer and genital malignoma of the women.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• Written consent for participation in this trail
• Age ≥18 years
• Female
• Breast or genital cancer of the woman
• Planned application of a Taxan-based chemotherapy regimen (Paclitaxel, Nab-Paclitaxel, Docetaxel) independent of the therapy line
• Taxan- and Platin-naivity
• Sufficient knowledge of the German language to assure an adequat survey of patient's history
Locations
Other Locations
Germany
University Hospital of Ulm
RECRUITING
Ulm
Contact Information
Primary
Angelina FINK, Dr. med.
angelina.fink@uniklinik-ulm.de
+4973150058688
Time Frame
Start Date: 2024-04-17
Estimated Completion Date: 2027-03-31
Participants
Target number of participants: 150
Treatments
Active_comparator: Hilotherapy
Cooling of hands and feet during Taxan-based chemotherapy
No_intervention: No Cooling
No cooling of hands and feet during Taxan-based chemotherapy
Related Therapeutic Areas
Sponsors
Collaborators: Hilotherm
Leads: University of Ulm